Best Growth Stocks to Buy for May 26th
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today May 26th:
Centene CNC: This well-diversified healthcare company, that primarily provides a set of services to the government sponsored healthcare programs, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.3% over the last 60 days.
Centene Corporation Price and Consensus
Centene Corporation price-consensus-chart | Centene Corporation Quote
Centene has a PEG ratio of 0.46 compared with 1.05 for the industry. The company possesses a Growth Score of A.
Sanmina SANM: This company, which is a global provider of electronics contract manufacturing services, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.
Sanmina Corporation Price and Consensus
Sanmina Corporation price-consensus-chart | Sanmina Corporation Quote
Sanmina has a PEG ratio of 0.79 compared with 1.07 for the industry. The company possesses a Growth Score of A.
DaVita DVA: This company, which is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD), carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.4% over the last 60 days.
DaVita has a PEG ratio of 0.65 compared with 2.18 for the industry. The company possesses a Growth Score of B.
See the full list of top ranked stocks here.
Learn more about the Growth score and how it is calculated here.
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.9% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>This article originally published on Zacks Investment Research (zacks.com).
